OTRK
Ontrak, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.33
+358.19%Income statement
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.2M | 10.8M | 12.7M | 14.5M | 84.1M |
| Cost of Revenue | 4.3M | 4.0M | 3.9M | 7.5M | 31.2M |
| Gross Profit | 5.9M | 6.8M | 8.8M | 7.1M | 52.9M |
| Operating Expenses | |||||
| R&D Expense | 5.0M | 4.6M | 6.6M | 11.0M | 18.3M |
| SG&A Expense | 20.3M | 19.7M | 22.8M | 39.3M | 53.7M |
| General & Admin Expense | 17.6M | 17.0M | 19.3M | 34.3M | 43.8M |
| Selling & Marketing Expense | 2.7M | 2.7M | 3.6M | 5.0M | 9.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 25.2M | 24.3M | 29.5M | 50.2M | 71.9M |
| Cost and Expenses | 29.6M | 28.3M | 33.4M | 57.7M | 103.2M |
| Operating Income (EBIT) | (19.4M) | (17.5M) | (20.7M) | (43.2M) | (19.0M) |
| Non-Operating | |||||
| Interest Income | — | (5.9M) | — | — | — |
| Interest Expense | 8.6M | 1.8M | 7.2M | 3.9M | 8.0M |
| Net Interest Income | (8.6M) | (7.7M) | (7.2M) | (3.9M) | (8.0M) |
| Other Non-Op Income/Expense | (8.6M) | (8.0M) | (7.3M) | (8.3M) | (18.0M) |
| Non-Operating Income (excl Interest) | 5.9M | 6.2M | 123.0K | 4.4M | 10.0M |
| EBT (Pre-Tax Income) | (27.9M) | (25.5M) | (28.0M) | (51.5M) | (37.0M) |
| Income Tax Expense | — | — | (80.0K) | 88.0K | 153.0K |
| Bottom Line | |||||
| Net Income | (27.9M) | (25.5M) | (27.9M) | (51.6M) | (37.1M) |
| Earnings from Cont. Ops | (27.9M) | (25.5M) | (27.9M) | (51.6M) | (37.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (81.4M) | (25.5M) | (36.9M) | (60.5M) | (46.1M) |
| Per Share | |||||
| Basic EPS | ($15.80) | ($5.49) | ($5.99) | ($13.30) | ($11.95) |
| Diluted EPS | ($15.80) | ($5.49) | ($5.99) | ($13.30) | ($11.95) |
| Revenue Per Share | $1.85 | $2.34 | $2.73 | $3.74 | $27.06 |
| Shares | |||||
| Basic Shares Outstanding | 5.5M | 4.6M | 4.7M | 3.9M | 3.1M |
| Diluted Shares Outstanding | 5.5M | 4.6M | 4.7M | 3.9M | 3.1M |
| Profitability Metrics | |||||
| EBITDA | (23.9M) | (22.6M) | (14.4M) | (42.4M) | (24.7M) |
| D&A | 1.4M | 1.1M | 6.4M | 5.2M | 4.3M |
| EBIT | (25.3M) | (23.7M) | (20.8M) | (47.6M) | (29.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2025